The BLIMP Balloon in Coronary Interventions

January 26, 2023 updated by: Universitaire Ziekenhuizen KU Leuven

A Prospective, Multi-Center Registry, Randomized Trial for Evaluation of Effectiveness of the Blimp Scoring Balloon in Lesions Not Crossable With Conventional Balloon or Microcatheter.

The purpose of this study is to investigate the effectivness of the Blimp Scoring balloon compared to current available CTO balloon catheters.

Study Overview

Detailed Description

For this study two case situations are being considered.

6.1.1 Case Situation A Guidewire crossed the lesion, micro catheter does not cross

Case situation A is the circumstansis where a physician is using a guidewire in combination with a micro catheter. When in such case the guidewire is crossing at a certain moment of the procedure and the micro catheter not a balloon crossing attempt is one of the current common options as next step.

For the study the physician will go through following steps

  1. select alternating in 50% of these cases his current first choice regular balloon (≤ 1.5 (mm) OD) and in the other 50% of cases the Blimp.
  2. If first choice regular balloon does not cross select the Blimp and if the Blimp has been first choice select regular first choice balloon.
  3. If step 2 is not succesfull take a 6F guide extension and repeat sequence of step 1&2.
  4. If step 3 is also not succesfull report how else succeeded (e.g. tonus, balloon rupture, carlino, rotablation, subintimal cross…) or not.

See also appendix I for a flow chart case situation A.

6.1.2 Case Situation B Small balloon catheter (≤ 1.5 (mm)) needed for procedure- no micro catheter used.

Case situation B is the circumstansis where a physician is in the stage of a procedure where he/ she would normally want to select a small balloon catheter ((≤ 1.5 (mm)) to cross an occluded or subtotlal stenotic segment of the coronary artery. When in such case the balloon catheter is not crossing the selection/ attempt with another balloon is one of the current common options as next step.

For the study the physician will go through following steps

  1. select alternating in 50% of these cases his current first choice regular balloon (≤ 1.5 (mm) OD) and in the other 50% of cases the Blimp.
  2. If first choice regular balloon does not cross select the Blimp and if the Blimp has been first choice select regular first choice balloon.
  3. If step 2 is not succesfull take a 6F guide extension and repeat sequence of step 1&2.
  4. If step 3 is also not succesfull report how else succeeded (e.g. tonus, balloon rupture, carlino, rotablation, subintimal cross…) or not.See also appendix I for a flow chart of case situation B.

6.1.3 Use of the Blimp during the study

The Blimp should be used conform its Instruction For Use (IFU). Following techniques can be attemted to cross the lesion.

  1. Regular balloon crossing of lesion if no significant resistance is felt.
  2. Application of distal force/ push to the tip of Blimp against the proximal cap of the occlusion/subtotal lesion for 5-10 seconds to allow cap penetration due to spring principle of Blimp shaft.
  3. If no progressing in step 2 keep distal force/ push to the tip of the Blimp and inflate to 25-30 ATM to attempt wedging/ scoring of the proximal cap.
  4. Repeat step 2&3 up to three times to see if proximal cap/ crossing progression is made.
  5. If after multiple attemps of step 2&3 no progression is demonstrated it should be concluded that the Blimp was unsuccesfull in crossing.

6.1.4 Study population and number of subjects A total 128 patients which are being targeted for percutaneous coronary intervention are selected for this study. Pased on power calculations, 128 patiants are sufficient to demonstrate a statistical significant difference in outcome (P<0.05) with 80% power.

6.1.5 Inclusion/exclusion criteria Patients will be enrolled if they require percutaneous coronary intervention (PCI) procedure and

  1. During the case a micro catheter is being used which is not able to cross after crossing of the guidewire (case situation A).
  2. During the case a small balloon catheter (≤ 1.5 (mm) OD) is being used and is not able to cross the target lesion (case situation B) .

Patients which under normal conditions would be excluded for a PCI procedure by the hospital will be excluded from the study.

6.1.6 Rational and justification of chosen study design The Blimp is intended for balloon dilatation of a coronary artery subtotal lesion/occlusions.

Due to its

  • very small profile
  • high rated burst pressure and
  • guidewire scoring element over the balloon

the device has several features which can improve the crossabiltiy and initial dilation of severe occluded vessels. The study has been designed such to investigate in an objective and controlled manner if the Blimp Scoring balloon is providing an improved procedural success rate in these matters.

Study Type

Interventional

Enrollment (Actual)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Genk, Belgium, 3600
        • ZOL Genk
    • Brabant
      • Leuven, Brabant, Belgium, 3001
        • Johan Bennett

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Severe coronary lesion where microcatheter or dilatation balloon does not cross

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment with BLIMP first
Using BLIMP balloon to cross lesion
Active Comparator: Treatment with low-profile balloon first
using low profile balloon to cross lesion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful crossing through lesion and dilatation with BLIMP or low profile balloon
Time Frame: The primary outcome is a procedural assessment
passing of BLIMP or low profile balloon through lesion. If device passess it will be determined a successful outcome, if it does not pass, an unsuccesful outcome.
The primary outcome is a procedural assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2019

Primary Completion (Actual)

March 28, 2021

Study Completion (Actual)

March 28, 2021

Study Registration Dates

First Submitted

March 28, 2019

First Submitted That Met QC Criteria

May 10, 2019

First Posted (Actual)

May 13, 2019

Study Record Updates

Last Update Posted (Actual)

January 27, 2023

Last Update Submitted That Met QC Criteria

January 26, 2023

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • S61686

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Percutaneous Coronary Intervention

Clinical Trials on BLIMP balloon

3
Subscribe